FDA recognizes psilocybin as ‘breakthrough therapy’ for depression
The only reference to psilocybin on the Food and Drug Administration’s website appears in the agency’s Bad Bug Book: Handbook of Foodborne Pathogenic Microorganisms and Natural Toxins, where the psychedelic compound is described as a “neurotoxin” found in mushrooms. The FDA’s dueling portrayals of psilocybin as a scary fungal neurotoxin and a promising treatment for depression…
Recent Comments